Evidence map›Paper›PMID 27783158›Full record

ReviewPediatric nephrology (Berlin, Germany)2017

Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology.

Samriti Dogra, Frederick Kaskel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Frontiers in physiology · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. [Research advances in the association between transient receptor potential cation channel 6 and kidney disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Samriti DograDivision of Pediatric Nephrology, Department of Pediatrics, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT, 06095, USA. sdogra@connecticutchildrens.org.
Frederick KaskelDivision of Pediatric Nephrology, Department of Pediatrics, Children's Hospital at Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Funding

DEVELOPMENTAL RENAL AND ELECTROLYTE PHYSIOLOGYT32DK007110 · NIDDK · YESHIVA UNIVERSITY · PI KASKEL, FREDERICK JEFFREY, MELAMED, MICHAL L · 1986 to 2021
$5.6M
NIDDK NIH HHS T32 DK007110
6 · The paper itself

Abstract

Steroid-resistant nephrotic syndrome remains a challenge to treat, but various efforts are underway to better understand the pathogenesis and improve patient outcomes. This review provides an update on the newer advances in understanding the molecular etiologies for a variety of podocyte abnormalities, potential circulating factors that may initiate and sustain the steroid-resistant state, genetic mutations, and precision medicine treatment modalities in this continuously perplexing disorder.

Indexed as

Adrenocorticotropic HormoneAge FactorsBiopsyCalcineurin InhibitorsChild, PreschoolDrug ResistanceGenetic TestingGlomerulosclerosis, Focal SegmentalGlucocorticoidsHumansImmunosuppressive AgentsInfantInfant, NewbornMicroscopy, ElectronMutationNephrotic SyndromeAdrenocorticotropic HormoneCalcineurin InhibitorsGlucocorticoidsImmunosuppressive AgentsPLAUR protein, humanReceptors, Urokinase Plasminogen ActivatorFocal segmental glomerulosclerosisGenetic testingGlomerular filtration barrierMinimal change diseasePodocyteSteroid-resistant nephrotic syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.